NCT03394651

Prostatic Obstruction Investigation Team Multicenter Study

The Current Status and Progression of Symptoms and Comorbidities Among Male Lower Urinary Tract Symptoms Patients in China: a Multicenter Study From Prostatic Obstruction Investigation Team (POInT)

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 11,500 (estimated)
• Sponsor: Changhai Hospital · Academic / Other
• Sex: Male
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

The present is a multicenter, observational study organized by the Prostatic Obstruction Investigation Team (POInT), with a main purpose of looking into the current status and symptom progression of male lower urinary tract symptoms patients in China.

Detailed description

Lower urinary tract symptoms (LUTS) is a common medical condition negatively affecting people's quality of life worldwide. LUTS may be caused by structural or functional abnormalities in 1 or more parts of the lower urinary tract, including bladder, prostate, internal and external urethral sphincter and distal urethra. Furthermore, evidence exists to demonstrate that LUTS is associate with lifestyle factors, systemic comorbidities and geriatric diseases, such as smoking, obesity, metabolic syndrome, chronic kidney diseases and chronic obstructive pulmonary disease etc. So far, there is lack of evidence to illustrate the symptom features and comorbidities among Chinese male LUTS patients. Therefore, this multicenter clinical study aims to investigate the present status and symptom progression among male LUTS patients in China.

Conditions

• Lower Urinary Tract Symptoms

Interventions

Type	Name	Description
DRUG	Oral medications to treat lower urinary tract symptoms	Patients in this group will receive oral medication(s) depending on doctors' prescriptions.
PROCEDURE	Minimal invasive transurethral prostate procedures	Patients in this group will receive surgical treatment.

Timeline

• Start date: 2018-04-01
• Primary completion: 2019-04-01
• Completion: 2022-04-01
• First posted: 2018-01-09
• Last updated: 2018-11-14

Locations

1 site across 1 country: China